Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ismigen for COPD Exacerbation Prevention (AIACE)
NCT02417649Phase 4Completed
- Sponsor
- Lallemand Inc.
- Start
- Sep 2009
- Primary completion
- Jul 2013
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of polyvalent mechanical bacterial lysate in chronic obstructive pulmonary disease (COPD), sponsored by Lallemand Inc.. Started Sep 2009; status: completed.
02
Drugs
polyvalent mechanical bacterial lysate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02417649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02417649.